WishBone Boosts Spine Offerings with Two New Acquisitions

WishBone Medical Inc., pediatric orthopedic company focused globally on the unmet needs of children suffering from orthopedic issues, announced its 5th and 6th strategic acquisition in the past 18 months by acquiring substantially all assets of Back 2 Basics Direct (B2B) and Orbbö Surgical, two privately-held medical device companies focused on research, development and commercialization of sterile packaged implants and surgical instruments for spinal fusion.
 
“These acquisitions strengthen WishBone’s position in the pediatric orthopedic market with the addition of nine (9) FDA cleared, sterile packaged, spinal fusion product lines with year one revenue projections in excess of $12M,” stated Dr. Robert Wertz, Global VP of Market Development, Spine & Sports Medicine, WishBone Medical. “Also, our go-to-market plans include the addition of Back 2 Basics’ enhanced carbon composite biomaterials platform to our product development roadmap which will allow us to deliver an innovative pipeline of highly differentiated and disruptive technologies across our entire pediatric implant portfolio.”
 
Kevin Blue, Chief Revenue Officer of WishBone Medical, added, “Our entry into the pediatric spine segment marks yet another important milestone in our company’s history. We’re always looking to provide highly differentiated products that deliver clinical benefits with the potential to dramatically improve the lives of pediatric patients worldwide. These latest transactions will continue to position WishBone as the leading provider of sterile packed, anatomically appropriate procedure kits in the wake of the COVID-19 era.”
 
“We’re excited to join WishBone to further develop and commercialize our carbon composite technology platform as they bring to bear industry leading product innovation,” commented Louis Keppler, MD, Co-Founder of B2B. “Since 2015, our goal has been to improve surgical outcomes and expand indications with this disruptive technology. Together, we will better serve the market and change the lives of children everywhere.”
 
WishBone’s vertically integrated subsidiary, Red Star Medical Solutions (RSMS), provides the company with a key competitive advantage and dominant position within the $2.5B global pediatric orthopedic market by reducing time to market up to 65 percent with in-house rapid prototyping, advanced manufacturing platforms and sterile packaging capabilities. RSMS is in discussion with the Indiana Economic Development Corporation (IEDC) to expand two of its production facilities in Whitley- and Marshall County, IN. WishBone will add to its global team of 165 with 20 new employees dedicated to the spine market segment and commercialize a full spectrum, enhanced carbon composite fiber product line for children who are still growing.